INTRODUCTION TO THE ARDELYX CLASs ACTION LAWSUIT

dark purple stock ticker with yell and white numbers in 3d used in Ardelyx class action lawsuit

If you suffered losses in Arbleyx stock, call Timothy L. Miles today for a free case evaluation

The Ardelyx class action lawsuit seeks to represent purchasers or acquirers of Ardelyx, Inc. (NASDAQ: ARDX) securities between October 31, 2023 and July 1, 2024, inclusive (the “Class Period”).  Captioned Yarborough v. Ardelyx, Inc., No. 24-cv-12119 (D. Mass.), the Ardelyx class action lawsuit charges Ardelyx and certain of Ardelyx’s top executives with violations of the Securities Exchange Act of 1934.

If you have suffered losses in Ardelyx  stock and are interested in becoming the lead plaintiff in the Ardelyx class action lawsuit seeks or have any inquiries regarding your rights as a shareholder, please reach out to Ardelyx Stock Loss Lawyer Timothy L. Miles at no cost. You can contact him by calling 855/846-6529, sending an e-mail to [email protected], or filling out a contact formLead plaintiff motions for the Ardelyx class action lawsuit seeks must be filed with the court no later than October 15, 2014.

Key Points of the Ardelyx Class Action Lawsuit

  1. Alleged false/misleading statements by Ardelyx during Class Period​
  2. Failure to disclose crucial information about XPHOZAH application process
  3. Ardelyx’s indecision on applying for TDAPA program inclusion
  4. Dependency on CMS’s 2025 ESRD PPS rule for XPHOZAH decision
  5. July 2, 2024: Ardelyx announces decision not to apply for TDAPA
  6. Significant stock price drop of over 30% following announcement
  7. XPHOZAH: Approved treatment for elevated phosphorus in CKD patients
  8. Focus on 550,000 ESRD patients in the United States
  9. Allegations of misleading investors about XPHOZAH’s market potential
  10. Potential impact on investor confidence in Ardelyx’s management
  11. Questions raised about Ardelyx’s decision-making process
  12. Implications for future drug commercialization strategies
  13. Possible financial consequences for affected investors
  14. Importance of transparent communication in biotechnology sector
  15. Highlighting risks associated with regulatory approval processes

THE LEAD PLAINTIFF DEADLINE IN THE CLASS ACTION against Ardelyx

​​Lead plaintiff motions for the Lead plaintiff motions for the Ardelyx class action lawsuit seeks must be filed with the court no later than October 15, 2014.​ When a securities class action is filed such as the Ardelyx class action lawsuit:

  1. The person who files the first complaint is required to publish a notice announcing the filing.
  2. Anyone who wants to be lead plaintiff on behalf of the class must thereafter file a motion to be appointed as lead plaintiff(s) no later than 60 days after the notice was published.

YOU HAVE TWO CHOICES IF YOU RECEIVE A NOTICE IN THE Ardelyx CLASS ACTION LAWSUIT

​​First, read the notice very carefully.  You have two choices. 

  • First, you can do nothing and remain a member of the class represented by lead counsel. 
  • Second, if you believe you have a large enough loss to justify it, you can opt out of the Ardelyx class action lawsuit and file your own separate lawsuit.

​Note, that if you opt-out, you will not be able to participate in any settlement or recovery obtained in the Ardelyx class action lawsuit.

THE LEAD PLAINTIFF PROCESS IN THE Ardelyx class action LAWSUIT

​Under the Private Securities Litigation Reform Act of 1995 (PSLRA):

  • Any investor who purchased and suffered losses in Ardelyx stock may seek appointment as lead plaintiff in the Ardelyx class action lawsuit.
  • A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. 
  • A lead plaintiff acts on behalf of all other class members in directing the class action lawsuit.
  • The lead plaintiff can select a law firm of its choice to litigate the securities class action lawsuit. 
  • An investor’s ability to share in any potential future recovery of the class action lawsuit is not dependent upon serving as lead plaintiff. 

THE BENEFITS OF SERVING AS A LEAD PLAINTIFF IN THE Ardelyx CLASS ACTION LAWSUIT

  1. Negotiating more competitive attorney fees and reducing litigation costs.
  2. Managing the litigation by overseeing the progress of the case and reviewing important filings.
  3. Participating in mediation and settlement discussions.
  4. Having a voice in decision-making processes regarding the settlement.
  5. No financial risk, as lead counsel covers all costs and expenses and are paid only if they secure a  settlement or judgment recovery for the class
  6. Potentially enjoying long-term benefits from governance reform resulting from the litigation.

THE RESPONSIBILITIES THE LEAD PLAINTIFF WILL HAVE IN THE Ardelyx CLASS ACTION LAWSUIT

  1. ​Selecting, monitoring, and overseeing Lead Counsel.
  2. Reviewing and commenting on court filings on behalf of the class.
  3. Discussing litigation strategies with the Lead Counsel.
  4. Attending depositions (if necessary) and giving a deposition.
  5. Attending hearings (if necessary).
  6. Participating in mediation and the trial (if necessary).
  7. Provide input on any decision concerning the settlement of the securities class action.

ELIGIBILITY CRITERIA FOR LEAD PLAINTIFF APPOINTMENT IN THE Ardelyx CLASS ACTION LAWSUIT

​To be eligible for appointment as the lead plaintiff in the Ardelyx class action lawsuit, an investor must meet the following criteria:

  1. Securities Acquisition: The investor must have purchased or acquired Ardelyx, Inc. (NASDAQ: ARDX) securities between October 31, 2023, and July 1, 2024.
  2. Financial Losses: The investor must have suffered financial losses as a direct result of the alleged securities fraud perpetrated by Ardelyx and its executives.
  3. Typicality and Adequacy: The investor’s legal claims must be typical of those asserted on behalf of the class, and they must demonstrate their ability to adequately represent the interests of the entire class through experience, resources, and the absence of conflicts of interest.

It is crucial to note that both domestic and international investors who meet these criteria are eligible to seek appointment as the lead plaintiff in the Ardelyx class action lawsuit, as courts have consistently recognized the rights of non-U.S. investors in securities class actions.

LEGAL REQUIREMENTS FOR PREVAILING IN THE Ardelyx CLASS ACTION LAWSUIT

  1. Material Misrepresentation or Omission​
  2. Scienter
  3. Connection to Securities Transaction
  4. Reliance
  5. Economic Loss
  6. Loss Causation

STAGES OF THE CLASS ACTION AGAINST Ardelyx

  1. Consolidation and Lead Plaintiff Appointment
  2. Filing of Consolidated Complaint
  3. Motion to Dismiss
  4. Class Certification
  5. Discovery
  6. Settlement Negotiations and Mediation
  7. Summary Judgment Motions
  8. Trial
  9. Appeals

Resources for Investors in the Ardelyx Class Action Lawsuit and Others